Evolving Role of Molecular Imaging With PET in Detecting and Characterizing Heterogeneity of Cancer Tissue at the Primary and Metastatic Sites, a Plausible Explanation for Failed Attempts to Cure Malignant Disorders

European Journal of Nuclear Medicine and Molecular Imaging - Germany
doi 10.1007/s00259-011-1787-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers

Oncologist
Cancer ResearchMedicineOncology
2017English

18f-FDG PET in Detecting Primary Breast Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2007English

Cure and Cosmesis in the Management of Primary Malignant Melanoma

British Journal of Cancer
Cancer ResearchOncology
1990English

The Evolving Role of Receptors as Predictive Biomarkers for Metastatic Breast Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2018English

Molecular Imaging of Prostate Cancer With 18f-Fluorodeoxyglucose PET

Nature Reviews Urology
Urology
2009English

The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival

Annals of Surgical Oncology
OncologySurgery
2019English

Role of PET/CT for Precision Medicine in Lung Cancer: Perspective of the Society of Nuclear Medicine and Molecular Imaging

Translational Lung Cancer Research
Oncology
2017English

The Evolving Role of Tissue Biospecimens in the Treatment of Cancer

2011English

Role of 18F FDG PET in Differentiating Benign and Malignant Primary Bone Tumors

Bangladesh Journal of Nuclear Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy